Loading company…
ME Instruments develops gene sequencing platforms, reagents, equipment, and software.
Founded in 2018 and based in Shenzhen, China, ME Instruments develops gene sequencing technologies and products. Its offerings include the UniSeq2000 clinical sequencing device, sequencing and enzyme reagents, ancillary equipment, and software. These products support pathogen testing, genetic screening, cancer diagnosis, and cardiovascular care. In June 2025, it closed Series C+ funding from Zhonghuijin Group and plans to build a sequencing platform production base in Lianyungang.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in